1. PC.01.8 SERUM DETERMINATION OF SQUAMOUS CELLULAR CARCINOMA ANTIGEN AS A BIOMARKER OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER: A PHASE III STUDY. (24th February 2016) Authors: Maddalo, G.; Marafatto, F.; Fassan, M.; Cardin, R.; Piciocchi, M.; Pozzan, C.; Zaninotto, G.; Ruol, A.; Castoro, C.; Rugge, M.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 2 Page Start: e70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity portal hypertension and complications onset in patients with advanced liver disease. (February 2019) Authors: Martini, A.; Marafatto, F.; Turato, C.; Novo, E.; Parola, M.; Biasiolo, A.; Quarta, S.; Ruvoletto, M.; Angeli, P.; Pontisso, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗